Lung Cancer Screening in Real World Has High False-Positive Rate
By Kelly YoungEdited by: David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD A pair of studies in JAMA Internal Medicine illustrate the difficulties of implementing lung cancer screening. In the first, eight Veterans Health Administration medical centers identified and screened patients using low-dose computed tomography (LDCT). Over 2100 patients who were eligible for screening based […]
Opportunities and challenges for lung cancer screening in China
Chuanli Ren, Chongxu Han Abstract China accounts for nearly half of the incidence and mortality of lung cancer in the world. Furthermore, trends in lung cancer in China are increasing younger in age and the situation is deteriorating. As a whole although screening for early lung cancer may cause a small fraction of overdiagnosis and anxiety of […]
AI early diagnosis could save heart and cancer patients
AI early diagnosis could save heart and cancer patients By Pallab GhoshScience correspondent, BBC News2 January 2018 Original Article: http://www.bbc.com/news/health-42357257 Researchers at an Oxford hospital have developed artificial intelligence (AI) that can diagnose scans for heart disease and lung cancer. The systems will save billions of pounds by enabling the diseases to be picked up much earlier. The heart disease […]
A supramolecular indicator displacement assay for acetyl amantadine
A supramolecular indicator displacement assay for acetyl amantadine, a proxy biomarker for spermidine/spermine N1-acetyltransferase (SSAT) activity Introduction Cancer is a leading cause of death worldwide.1 The number of new cancer cases is expected to increase 40% in the next 15 years in Canada due to an aging and growing population.2 Lung cancer is the most […]
Quest for Game Changing Lung Cancer Diagnostic Assay
HealthTech Innovation Hub and Surrey Memorial Hospital Rashid Ahmed, President & CEO Dr. James Bond, Chief of Thoracic Surgery, Surrey Memorial Hospital
